Analysis of the glycome and mRNA transcriptional profiles before and after stimulation of (normal and cancer) cells by TGF-β in several EMT models revealed upregulation or downregulation of specific glycan structures and glycogenes involved in biosynthesis of N-glycans, O-glycans and GSL-linked glycans (Fig. 4) (Li et al., 2016). The gene discussed is TGFB1; the disease is cancer.